查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2011012

数位病理市场：按类型、产品类型、应用和最终用户划分－2026-2032年全球市场预测

Digital Pathology Market by Type, Product, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

数位病理学市场预计到 2025 年将达到 14.4 亿美元，到 2026 年将成长到 16.6 亿美元，到 2032 年将达到 40.9 亿美元，复合年增长率为 16.05%。

主要市场统计数据
基准年 2025 14.4亿美元
预计年份：2026年 16.6亿美元
预测年份 2032 40.9亿美元
复合年增长率 (%) 16.05%

全面概述成像硬体、分析软体和资料基础设施如何整合，进而重塑诊断工作流程和调查流程。

数位病理学已从实验辅助手段发展成为现代诊断和研究基础设施的重要组成部分。本文将此领域定位为影像处理硬体、先进软体平台以及可扩展储存和通讯系统的融合，这些技术共同重塑了组织资料的采集、分析和说明方式。这些技术进步与不断变化的临床工作流程、监管要求以及远端协作的需求相交织，重新定义了病理学家、检查室管理人员和资讯学团队在提供诊断准确性和促进转化研究方面的角色。

分析正在加速病理服务领域采用新技术、新监管和新临床趋势，并重塑营运模式。

在技​​术创新、政策转变和临床范式演进的驱动下，数位病理学领域正经历着一场变革。扫描仪光学技术的进步、高通量切片数位化以及安全通讯系统的改进降低了技术门槛，使得数位化。

对近期关税调整如何影响病理生态系统内的筹资策略、供应商选择和供应链韧性进行详细分析。

美国近期关税调整为影像系统、扫描器及周边设备的筹资策略引入了新的变数，影响了全球供应链中多个供应商类别的决策。采购团队和供应链经理正在采取一系列措施，例如重新评估采购区域、调整预估的总到岸成本，以及寻找替代供应商，以保障计划进度和资本计画。这些调整正在影响设备选用、供应商谈判以及检查室现代化改造的进程。

透过对产品类型、工作流程阶段、临床应用和最终用户概况进行详细的细分洞察，可以製定有针对性的部署和商业化计划。

细分市场分析揭示了需求驱动因素和部署模式在产品线、临床工作流程、应用和最终用户中的集中位置，从而为有针对性的部署和商业化策略提供了框架。从产品角度来看，市场涵盖通讯系统、扫描器、软体和储存系统，其中软体进一步细分为云端部署和本地部署。这种细分突显了买家优先事项的差异：通讯系统和储存系统与基础设施投资密切相关，扫描器是资本设备的重点，而软体则倾向于决定工作流程的协调和分析能力。

区域市场动态和部署模式阐明了全球主要地区的策略机会和营运考量。

区域趋势正在影响美洲、欧洲、中东和非洲以及亚太地区的采用模式、监管参与和伙伴关係模式，为供应商和医疗机构创造了差异化的策略机会。在美洲，强大的研究基础设施和蓬勃发展的商业市场正在推动先进扫描器、人工智慧驱动的分析和企业级影像管理技术的早期应用。同时，报销框架和监管核准流程正在影响检验重点和临床部署计划。该地区的相关人员通常优先考虑与现有实验室资讯系统 (LIS) 的整合以及处理能力的最佳化，以支援高容量诊断工作流程。

深入了解影响整个数位病理生态系统采购决策和临床整合的供应商策略、伙伴关係模式和功能差异化。

产业巨头们正在整合各自的技术栈，投资于互通性，并拓展服务模式，以掌握诊断、研发和药物开发领域的机会。领先的供应商正透过整合高解析度扫描器、强大的影像管理平台和高级分析功能的端到端解决方案来脱颖而出，而新兴的专业软体供应商则专注于细分领域的分析、符合监管要求的AI检验以及云端原生协作工具。这些策略倡议反映了生态系统正朝着基于平台的产品和服务以及连接临床和商业应用场景的伙伴关係关係而成熟。

制定切实可行的分阶段策略，用于采购、检验和整合数位病理能力，同时确保互通性、管治和人才准备。

产业领导者应采取务实的分阶段方法来实施数位病理学，以平衡临床检验、工作流程整合和变更管理。首先，应确定与组织优先事项相符的高影响力用例，例如诊断亚专科和调查计画，并制定基于证据的检验计划，以证明其临床效用和营运效益。同时，在选择供应商时，互通性和资料管治应是至关重要的要求，以确保长期柔软性并符合当地法规。

本研究采用严谨的混合方法研究设计，结合一手访谈、技术评估和二手文献，以类似三角测量的方式检验趋势和细分框架。

本调查方法结合了质性访谈、技术环境映射和二手资讯的交叉检验，旨在建构稳健的分析证据基础。透过与临床负责人、实验室管理人员、供应商和监管专家进行结构化讨论，我们获得了关于技术采纳驱动因素、检验障碍和采购考虑等方面的主要见解。同时，技术评估检验了扫描器的规格、软体架构以及储存和通讯模式，以识别功能差异。这种多方面的方法确保了研究结果既能反映实际操作情况，又能反映技术发展趋势。

前瞻性的综合分析，将技术能力、临床检验和营运准备相结合，指导永续实施和可衡量的影响。

数位病理学正处于转折点，技术能力、临床需求和组织准备度在此交汇融合，为改进诊断和加速调查创造了可持续的机会。结论整合了以下几个关键主题：互通软体架构的重要性、检验的分析方法日益增长的相关性，以及应对供应链差异和区域监管细微差别的策略采购的必要性。这些要素共同构成了一份切实可行的蓝图，供希望从其在数位病理学领域的投资中获得可衡量成果的利害关係人相关人员。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：数位病理市场：按类型划分

  • 人类病理学
  • 兽医病理学

第九章：数位病理市场：依产品划分

  • 硬体
    • 展示
      • 市售产品
      • 医用级
      • 专业级
    • 扫描器
      • 明场扫描仪
      • 萤光扫描仪
    • 储存系统
  • 服务
    • 咨询及实施服务
    • 维护和支援服务
    • 培训服务
  • 软体
    • 影像管理系统（IMS）
    • 检查资讯系统（LIS）
    • 影像存檔和通讯系统（PACS）

第十章：数位病理市场：依应用领域划分

  • 生物标记发现
  • 疾病诊断
    • 感染疾病
    • 神经病学
    • 肿瘤学
  • 药物发现与开发
  • 远距病理诊断
  • 毒性测试
  • 培训和教育

第十一章 数位病理市场：依最终用户划分

  • 学术和研究机构
  • 合约研究机构
  • 政府和监管机构
  • 医院/诊断检查室
  • 製药和生物技术公司

第十二章 数字病理市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 数位病理市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 数位病理市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国数位病理市场

第十六章：中国数位病理市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3DHISTECH Ltd.
  • Aiforia Technologies PLC
  • Akoya Biosciences
  • Charles River Laboratories
  • Corista LLC
  • Danaher Corporation
  • Deep Bio Inc.
  • Epredia
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • Hamamatsu Photonics KK
  • Huron Digital Pathology
  • Indica Labs
  • Koninklijke Philips NV
  • Laboratory Corporation of America Holdings
  • Mikroscan Technologies, Inc.
  • Motic
  • Nikon Corporation
  • Olympus Corporation
  • OptraSCAN Inc.
  • Pathcore Inc.
  • PathPresenter Corporation
  • PerkinElmer, Inc.
  • Proscia, Inc.
  • Quest Diagnostics Incorporated
  • Sectra AB
  • Visiopharm A/S
  • Xybion Digital Inc.
Product Code: MRR-433498411CFD

The Digital Pathology Market was valued at USD 1.44 billion in 2025 and is projected to grow to USD 1.66 billion in 2026, with a CAGR of 16.05%, reaching USD 4.09 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.44 billion
Estimated Year [2026] USD 1.66 billion
Forecast Year [2032] USD 4.09 billion
CAGR (%) 16.05%

A comprehensive overview of how imaging hardware, analytics software, and data infrastructure converge to reshape diagnostic workflows and research pipelines

Digital pathology has evolved from an experimental adjunct to an integral component of contemporary diagnostic and research infrastructures. This introduction frames the field as a convergence of imaging hardware, sophisticated software platforms, and scalable storage and communication systems that collectively reshape how tissue-based data are acquired, analyzed, and managed. These technological advances intersect with changes in clinical workflows, regulatory expectations, and demands for remote collaboration, thereby redefining the roles of pathologists, laboratory managers, and informatics teams in delivering diagnostic certainty and enabling translational research.

As adoption accelerates, stakeholders face both opportunities and integration challenges. Implementation requires alignment across image acquisition modalities, image analysis algorithms, and enterprise-grade image management systems, with software options spanning cloud-based and on-premise deployments to meet diverse institutional constraints. Consequently, decision-makers must weigh interoperability, data governance, and clinical validation pathways alongside operational priorities such as throughput, turnaround times, and workforce upskilling. This introduction sets a foundation for subsequent sections by outlining the core components, emergent drivers, and pragmatic considerations that will guide strategic planning and investment in digital pathology initiatives.

An analysis of emerging technological, regulatory, and clinical dynamics that are accelerating adoption and reshaping operational models across pathology services

The landscape of digital pathology is undergoing transformative shifts driven by technological innovation, policy recalibration, and evolving clinical paradigms. Advances in scanner optics, high-throughput slide digitization, and secure communication systems have reduced technical friction and enabled broader decentralization of pathology services. At the same time, image analysis has progressed from basic morphometric tools to AI-enabled algorithms capable of extracting multiplexed phenotypic and spatial biomarkers, thereby expanding the clinical and research use cases of digitized histology.

Concurrently, the maturation of software ecosystems, including both cloud-based solutions and on-premise platforms, has introduced new modalities of deployment and scale. Cloud options accelerate collaboration across institutions and support centralized analytics while on-premise systems continue to appeal for latency-sensitive workflows and strict data residency requirements. Moreover, shifting regulatory frameworks and growing emphasis on telepathology and remote consultation have propelled adoption in settings that previously relied solely on conventional microscopy. Taken together, these shifts are not isolated; they interact to create a feedback loop where improved algorithms demand richer data, and richer data prompt investments in storage and communication, thereby accelerating the next wave of capability development and clinical integration.

A focused assessment of how recent tariff adjustments have reshaped procurement strategies, vendor sourcing decisions, and supply chain resilience in the pathology ecosystem

Recent tariff changes in the United States have introduced a new variable into procurement strategies for imaging systems, scanners, and ancillary hardware, and they have influenced global supply chain decisions across multiple vendor categories. Procurement teams and supply chain managers are responding by reassessing sourcing geographies, recalibrating total landed cost assumptions, and exploring alternative suppliers to protect project timelines and capital planning. These adjustments have implications for equipment selection, vendor negotiations, and the cadence of laboratory modernization efforts.

In parallel, the tariffs have prompted suppliers to revisit manufacturing footprints and component sourcing strategies to mitigate exposure; some vendors are accelerating diversification of production sites, while others are absorbing short-term cost impacts to preserve market access. For purchasers, this environment underscores the importance of flexible contracting clauses and longer lead-time visibility to avoid disruption. Moreover, the tariff context amplifies incentives to evaluate software-centric solutions and cloud-based services where physical hardware exposure is reduced, though this shift also raises considerations around data sovereignty and recurring operating expenditures. Overall, the tariff changes create an imperative for strategic procurement that balances cost, vendor resilience, and long-term technical requirements.

Deep segmentation insights that align product categories, workflow stages, clinical applications, and end-user profiles to inform targeted deployment and commercialization planning

Segmentation analysis reveals where demand drivers and adoption patterns concentrate across product lines, clinical workflows, applications, and end users, providing a framework for targeted deployment and commercialization strategies. From a product perspective, the market encompasses communication systems, scanners, software, and storage systems, with software further differentiated into cloud-based and on-premise offerings; this delineation highlights distinct buyer priorities, where communication systems and storage often align with infrastructure investments, scanners serve as capital equipment focal points, and software dictates workflow orchestration and analytics capabilities.

When viewed through the lens of workflow, the ecosystem spans image acquisition, image analysis, and image management, which together form the core operational pipeline from specimen digitization to actionable insight. Application-driven segmentation illuminates strategic value pools including biomarker discovery, disease diagnosis, drug development, telepathology, toxicology studies, and training and education, with disease diagnosis further refined into infectious diseases, neurology, and oncology, each demanding specialized analytic approaches and validation pathways. Finally, end-user segmentation differentiates academic and research institutes, contract research organizations, government and regulatory bodies, hospitals and diagnostic labs, and pharmaceutical and biotechnology companies, reflecting variations in procurement cycles, regulatory priorities, and integration complexity. By integrating these segmentation dimensions, stakeholders can prioritize investments that align with institutional capabilities and unmet clinical needs.

Regional market dynamics and adoption patterns that delineate strategic opportunities and operational considerations across major global geographies

Regional dynamics influence adoption patterns, regulatory engagement, and partnership models across the Americas, Europe, Middle East & Africa, and Asia-Pacific, creating differentiated strategic opportunities for vendors and healthcare organizations. In the Americas, strong research infrastructure and an active commercial market foster early uptake of advanced scanners, AI-enabled analysis, and enterprise-grade image management, while reimbursement frameworks and regulatory pathways shape validation priorities and clinical deployment timelines. Stakeholders here often prioritize integration with existing laboratory information systems and throughput optimization to support high-volume diagnostic workflows.

Across Europe, the Middle East & Africa, and Asia-Pacific, diverse market maturities and regulatory environments create both challenges and opportunities. Some countries within Europe and Asia-Pacific demonstrate rapid adoption driven by national digital health initiatives and investments in telepathology to address workforce shortages, whereas parts of the Middle East & Africa emphasize capacity building and partnerships with academic centers. In Asia-Pacific, expanding clinical trial activity and a growing biotech sector support demand for solutions tailored to drug development and biomarker discovery. Transitional approaches that account for regional data governance, interoperability standards, and local talent development prove essential for successful implementations in each geography.

Insights into vendor strategies, partnership models, and capability differentiation that influence procurement decisions and clinical integration across the digital pathology ecosystem

Key industry players are consolidating technology stacks, investing in interoperability, and expanding service models to capture opportunities across diagnostics, research, and drug development. Leading vendors are differentiating through end-to-end offerings that combine high-resolution scanners, robust image management platforms, and advanced analytics, while an emerging cohort of specialized software providers focuses on niche analytics, regulatory-grade AI validation, and cloud-native collaboration tools. These strategic moves reflect a maturation of the ecosystem toward platform-based delivery and partnerships that bridge clinical and commercial use cases.

Partnership dynamics have also shifted, with alliances forming between imaging hardware manufacturers and software companies to accelerate validated workflows and streamline buyer journeys. Concurrently, service providers and contract research organizations are integrating digital pathology capabilities to offer higher-value preclinical and clinical research services. For buyers, vendor selection increasingly prioritizes demonstrated interoperability, certification pathways, and the ability to deliver reproducible, explainable analytics that align with regulatory expectations. Vendors that can demonstrate clinical validation, offer flexible deployment models, and provide comprehensive support for workflow integration will maintain competitive advantage as the market evolves.

Actionable, phased strategies for procuring, validating, and integrating digital pathology capabilities while safeguarding interoperability, governance, and workforce readiness

Industry leaders should adopt a pragmatic, phased approach to digital pathology adoption that balances clinical validation, workflow integration, and change management. Begin by identifying high-impact use cases that align with institutional priorities, such as diagnostic subspecialties or research programs, and establish evidence-based validation plans that demonstrate clinical utility and operational benefit. Simultaneously, make interoperability and data governance non-negotiable criteria when selecting vendors to ensure long-term flexibility and compliance with regional regulations.

Leaders should also invest in workforce development and cross-disciplinary collaboration to maximize the value of digitized slides and analytics. Training programs that combine pathology expertise with data science literacy will accelerate algorithm adoption and ensure responsible interpretation of AI outputs. From a procurement perspective, explore flexible contracting models that mitigate tariff exposure and enable staged rollouts, while considering a balance between cloud-based and on-premise deployments to meet latency, security, and cost objectives. Finally, prioritize partnerships that offer comprehensive implementation support, including integration with laboratory information systems and tailored professional services to expedite validation and adoption across clinical and research settings.

A rigorous mixed-methods research design that triangulates primary interviews, technical assessments, and secondary literature to validate trends and segmentation frameworks

The research methodology combines qualitative interviews, technology landscape mapping, and cross-validation of secondary sources to build a robust evidence base for analysis. Structured discussions with clinical leaders, laboratory directors, vendors, and regulatory experts provided primary insights into adoption drivers, validation hurdles, and procurement considerations, while technical assessments examined scanner specifications, software architectures, and storage and communication paradigms to understand capability differentials. This multipronged approach ensures that findings reflect both operational realities and technological trajectories.

Secondary analysis supplemented primary inputs with a systematic review of peer-reviewed literature, regulatory guidance documents, and publicly available vendor materials to contextualize trends and technological performance. Comparative assessments identified patterns in deployment models, interoperability approaches, and clinical use cases, while synthesis workshops reconciled divergent perspectives and validated segmentation frameworks. Throughout the process, methodological rigor emphasized triangulation of sources, transparency about assumptions, and continuous stakeholder validation to enhance credibility and relevance for decision-makers across clinical, research, and commercial domains.

A forward-looking synthesis that aligns technological capability, clinical validation, and operational readiness to guide sustained adoption and measurable impact

Digital pathology stands at an inflection point where technological capability, clinical need, and organizational readiness converge to create durable opportunities for improved diagnostics and accelerated research. The conclusion synthesizes core themes: the centrality of interoperable software architectures, the growing importance of validated analytics, and the imperative for strategic procurement that accommodates supply chain volatility and regional regulatory nuance. Together, these elements shape a pragmatic roadmap for stakeholders seeking to derive measurable outcomes from digital pathology investments.

Looking ahead, success will hinge on aligning clinical validation with workflow redesign, investing in human capital, and choosing partners that can deliver integrated solutions and sustained implementation support. The most successful organizations will treat digital pathology not as a stand-alone technology purchase but as a platform for continuous improvement that spans diagnostics, translational research, and drug development. By maintaining a focus on reproducibility, explainability, and governance, institutions can translate technological promise into tangible clinical and scientific advances while managing operational and regulatory complexity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Digital Pathology Market, by Type

  • 8.1. Human Pathology
  • 8.2. Veterinary Pathology

9. Digital Pathology Market, by Product

  • 9.1. Hardware
    • 9.1.1. Displays
      • 9.1.1.1. Consumer off the Shelf
      • 9.1.1.2. Medical Grade
      • 9.1.1.3. Professional Grade
    • 9.1.2. Scanners
      • 9.1.2.1. Brightfield Scanners
      • 9.1.2.2. Fluorescence Scanners
    • 9.1.3. Storage Systems
  • 9.2. Services
    • 9.2.1. Consulting & Implementation Services
    • 9.2.2. Maintenance & Support Services
    • 9.2.3. Training Services
  • 9.3. Software
    • 9.3.1. Image Management Systems (IMS)
    • 9.3.2. Laboratory Information Systems (LIS)
    • 9.3.3. Picture Archiving and Communication Systems (PACS)

10. Digital Pathology Market, by Application

  • 10.1. Biomarker Discovery
  • 10.2. Disease Diagnosis
    • 10.2.1. Infectious Diseases
    • 10.2.2. Neurology
    • 10.2.3. Oncology
  • 10.3. Drug Discovery & Development
  • 10.4. Telepathology
  • 10.5. Toxicology Studies
  • 10.6. Training & Education

11. Digital Pathology Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Contract Research Organizations
  • 11.3. Government & Regulatory Bodies
  • 11.4. Hospitals & Diagnostic Labs
  • 11.5. Pharmaceutical & Biotechnology Companies

12. Digital Pathology Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Digital Pathology Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Digital Pathology Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Digital Pathology Market

16. China Digital Pathology Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3DHISTECH Ltd.
  • 17.6. Aiforia Technologies PLC
  • 17.7. Akoya Biosciences
  • 17.8. Charles River Laboratories
  • 17.9. Corista LLC
  • 17.10. Danaher Corporation
  • 17.11. Deep Bio Inc.
  • 17.12. Epredia
  • 17.13. F. Hoffmann-La Roche Ltd.
  • 17.14. FUJIFILM Holdings Corporation
  • 17.15. General Electric Company
  • 17.16. Hamamatsu Photonics K.K.
  • 17.17. Huron Digital Pathology
  • 17.18. Indica Labs
  • 17.19. Koninklijke Philips N.V.
  • 17.20. Laboratory Corporation of America Holdings
  • 17.21. Mikroscan Technologies, Inc.
  • 17.22. Motic
  • 17.23. Nikon Corporation
  • 17.24. Olympus Corporation
  • 17.25. OptraSCAN Inc.
  • 17.26. Pathcore Inc.
  • 17.27. PathPresenter Corporation
  • 17.28. PerkinElmer, Inc.
  • 17.29. Proscia, Inc.
  • 17.30. Quest Diagnostics Incorporated
  • 17.31. Sectra AB
  • 17.32. Visiopharm A/S
  • 17.33. Xybion Digital Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIGITAL PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DIGITAL PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HUMAN PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HUMAN PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HUMAN PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY VETERINARY PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY VETERINARY PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY VETERINARY PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONSUMER OFF THE SHELF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONSUMER OFF THE SHELF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONSUMER OFF THE SHELF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY MEDICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY MEDICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY MEDICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PROFESSIONAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PROFESSIONAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PROFESSIONAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY BRIGHTFIELD SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY BRIGHTFIELD SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY BRIGHTFIELD SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY FLUORESCENCE SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY FLUORESCENCE SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY FLUORESCENCE SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY STORAGE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY STORAGE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY STORAGE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONSULTING & IMPLEMENTATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONSULTING & IMPLEMENTATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONSULTING & IMPLEMENTATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TRAINING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TRAINING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TRAINING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY IMAGE MANAGEMENT SYSTEMS (IMS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY IMAGE MANAGEMENT SYSTEMS (IMS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY IMAGE MANAGEMENT SYSTEMS (IMS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS (LIS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TELEPATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TELEPATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TELEPATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TOXICOLOGY STUDIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TOXICOLOGY STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY BODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY BODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GOVERNMENT & REGULATORY BODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. GCC DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GCC DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 215. GCC DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 216. GCC DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 218. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 219. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 220. GCC DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. GCC DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. G7 DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 248. G7 DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 249. G7 DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 251. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 252. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 253. G7 DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. G7 DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 255. G7 DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. NATO DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 259. NATO DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 260. NATO DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 261. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 262. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 263. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 264. NATO DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. NATO DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 266. NATO DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)